OYE Therapeutics has been authorized to initiate clinical development of its OYE-101 caffeine injection after the U.S. FDA cleared its Investigational New Drug applications. OYE-101 is a novel ...
In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...
WILMINGTON, DE — NRx Pharmaceuticals, Inc. said it has secured Fast Track designation from the U.S. Food and Drug Administration for NRX-100, a preservative-free ketamine formulation aimed at treating ...
Lipocine ( (LPCN)) has shared an announcement. On January 20, 2026, Lipocine announced it has completed enrollment and dosing of 90 patients in its Phase 3 clinical trial of LPCN 1154, an oral ...
Leaders of the D.S.M., the world’s most influential psychiatric manual, have been split for more than five years over whether ...
New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...
The FDA designation expands the drug's potential patient pool tenfold, to an estimated 13 million Americans who consider suicide annually. Clinical trials demonstrated rapid and statistically ...
Depression, one of the most prevalent mental health disorders worldwide, is characterized by persistent feelings of sadness, impaired daily functioning and a loss of interest in daily activities, ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...
Major depressive disorder (MDD) affects about 10.4 percent of adults in one year and 20.6 percent over a lifetime (Hasin, 2018). Unfortunately, by themselves, psychotherapy and antidepressants only ...
Researchers looked at 30 depression symptoms in middle-aged people to see if any were associated with dementia later in life. They found six that stood out. A recent study linked certain symptoms of ...
Different types of depression affect the body in different ways. Atypical, energy-related depression raises the risk of diabetes, while melancholic depression increases the likelihood of heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results